Up 28% since its later-stage round, Jun 2025 ($310.0M post-money).
- ·6 fund marks: filer, period, implied $/share
Membership and data by Private Market View
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Triveni Bio funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2025 | Later Stage VC (Series B) | $115.0M | ▮ | ▮ |
| Oct 2023 | Early Stage VC (Series A) | $91.6M | ▮ | ▮ |
Membership and data by Private Market View
Triveni Bio valuation
Triveni Bio is valued at approximately $398 million as of Oct 2026. The figure is set by institutional fund marks. The reference point is its later-stage round in Jun 2025, at a $310 million post-money valuation; the current figure is up 28% since.
How much has Triveni Bio raised?
Triveni Bio has raised $232 million across 2 recorded rounds since 2023. The largest was a $91.6 million Series A in Oct 2023; the most recent was an $115 million Series B in Jun 2025.
Institutional holders and vehicles
1 SEC-registered fund reported 6 fair-value marks on Triveni Bio between May 2025 and May 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
Comparable companies
Comparable drug discovery names by valuation on PrivateMarketView: Mythic Therapeutics ($293 million), City Therapeutics ($285 million) and Convergent Therapeutics ($280 million).
How Triveni Bio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Triveni Bio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by institutional fund marks. Question about this number? Full methodology →
Frequently asked about Triveni Bio
- What is Triveni Bio worth?
- Triveni Bio is valued at $398.1M as of Oct 2026. Up 28% since its later-stage round, Jun 2025 ($310.0M post-money).
- How much has Triveni Bio raised?
- Triveni Bio has raised $231.6M in total funding across 2 recorded rounds.
- When did Triveni Bio last raise?
- Triveni Bio last raised in Jun 2025 (Later Stage VC (Series B)), raising $115.0M.